Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 764

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family

Open access
Ye, Richard D., Boulay, François, Wang, Ji Ming, Dahlgren, Claes, Gerard, Craig, Parmentier, Marc, Serhan, Charles N., Murphy, Philip M.·2009·Pharmacological Reviews
DOI 10.1124/pr.109.001578
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1124/pr.109.001578

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 392

  1. Abo, 1991, Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1, Nature, 353, 668, 10.1038/353668a0 · DOI · Paper page
  2. Agarwal, 1989, Altered free cytosolic calcium changes and neutrophil chemotaxis in patients with juvenile periodontitis, J Periodontal Res, 24, 149, 10.1111/j.1600-0765.1989.tb00870.x · doi:10.1111/j.1600-0765.1989.tb00870.x
  3. Ali, 1999, Chemoattractant receptor cross-desensitization, J Biol Chem, 274, 6027, 10.1074/jbc.274.10.6027 · DOI · Paper page
  4. Ali, 1993, Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitization, J Biol Chem, 268, 24247, 10.1016/S0021-9258(20)80517-1 · doi:10.1016/s0021-9258(20)80517-1
  5. Aliberti, 2002, Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity, Nat Immunol, 3, 76, 10.1038/ni745 · DOI · Paper page
  6. Aliberti, 2002, Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection, J Exp Med, 196, 1253, 10.1084/jem.20021183 · DOI · Paper page
  7. Allen, 1986, Preparation and properties of an improved photoaffinity ligand for the N-formyl peptide receptor, Biochim Biophys Acta, 882, 271, 10.1016/0304-4165(86)90248-5 · doi:10.1016/0304-4165(86)90248-5
  8. Almkvist, 2004, Newcastle disease virus neuraminidase primes neutrophils for stimulation by galectin-3 and formyl-Met-Leu-Phe, Exp Cell Res, 298, 74, 10.1016/j.yexcr.2004.04.006 · DOI
  9. Almkvist, 2001, Lipopolysaccharide-induced gelatinase granule mobilization primes neutrophils for activation by galectin-3 and formylmethionyl-Leu-Phe, Infect Immun, 69, 832, 10.1128/IAI.69.2.832-837.2001 · DOI
  10. Alvarez, 1996, Molecular evolution of the N-formyl peptide and C5a receptors in non-human primates, Immunogenetics, 44, 446, 10.1007/BF02602806 · DOI
  11. Amatruda, 1995, Signal transduction by the formyl peptide receptor. Studies using chimeric receptors and site-directed mutagenesis define a novel domain for interaction with G-proteins, J Biol Chem, 270, 28010
  12. Amatruda, 1991, G alpha 16, a G protein alpha subunit specifically expressed in hematopoietic cells, Proc Natl Acad Sci U S A, 88, 5587, 10.1073/pnas.88.13.5587 · DOI · Paper page
  13. Arcaro, 1993, Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses, Biochem J, 296, 297, 10.1042/bj2960297 · DOI · Paper page
  14. Aruffo, 1987, Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system, Proc Natl Acad Sci U S A, 84, 8573, 10.1073/pnas.84.23.8573 · DOI · Paper page
  15. Aswanikumar, 1977, Demonstration of a receptor on rabbit neutrophils for chemotactic peptides, Biochem Biophys Res Commun, 74, 810, 10.1016/0006-291X(77)90375-8 · doi:10.1016/0006-291x(77)90375-8
  16. Babior, 2002, The neutrophil NADPH oxidase, Arch Biochem Biophys, 397, 342, 10.1006/abbi.2001.2642 · DOI · Paper page
  17. Bae, 2004, Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling, J Immunol, 173, 607, 10.4049/jimmunol.173.1.607 · DOI · Paper page
  18. Bae, 2003, Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils, Mol Pharmacol, 64, 721, 10.1124/mol.64.3.721 · DOI
  19. Baek, 1996, Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries, J Biol Chem, 271, 8170, 10.1074/jbc.271.14.8170 · DOI
  20. Bao, 1992, Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1,FPRH2) to chromosome 19, Genomics, 13, 437, 10.1016/0888-7543(92)90265-T · DOI · Paper page
  21. Baranova, 2005, Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases, J Biol Chem, 280, 8031, 10.1074/jbc.M405009200 · DOI · Paper page
  22. Bellner, 2005, A proinflammatory peptide from herpes simplex virus type 2 glycoprotein G affects neutrophil, monocyte, and NK cell functions, J Immunol, 174, 2235, 10.4049/jimmunol.174.4.2235 · DOI
  23. Bennett, 1980, The bacterial factors which stimulate neutrophils may be derived from procaryote signal peptides, FEBS Lett, 116, 57, 10.1016/0014-5793(80)80528-X · doi:10.1016/0014-5793(80)80528-x
  24. Bennett, 2001, Partial phosphorylation of the N-formyl peptide receptor inhibits G protein association independent of arrestin binding, J Biol Chem, 276, 49195, 10.1074/jbc.M106414200 · doi:10.1074/jbc.m106414200
  25. Bentwood, 1980, The sequential release of granule constitutents from human neutrophils, J Immunol, 124, 855, 10.4049/jimmunol.124.2.855 · DOI · Paper page
  26. Betten, 2001, A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis, J Clin Invest, 108, 1221, 10.1172/JCI13430 · DOI
  27. Björkman, 2008, Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1, J Leukoc Biol, 83, 245, 10.1189/jlb.0607-408 · doi:10.1189/jlb.0607-408
  28. Bokoch, 1984, Inhibition of receptor-mediated release of arachidonic acid by pertussis toxin, Cell, 39, 301, 10.1016/0092-8674(84)90008-4 · DOI · Paper page
  29. Bokoch, 1984, Purification and properties of the inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase, J Biol Chem, 259, 3560, 10.1016/S0021-9258(17)43131-0 · DOI · Paper page
  30. Bommakanti, 1992, Reconstitution of a physical complex between the N-formyl chemotactic peptide receptor and G protein. Inhibition by pertussis toxin-catalyzed ADP ribosylation, J Biol Chem, 267, 7576, 10.1016/S0021-9258(18)42555-0 · DOI
  31. Bommakanti, 1994, Characterization of complex formation between Gi2 and octyl glucoside solubilized neutrophil N-formyl peptide chemoattractant receptor by sedimentation velocity, Biochim Biophys Acta, 1209, 69, 10.1016/0167-4838(94)90138-4 · DOI
  32. Bommakanti, 1995, Extensive contact between Gi2 and N-formyl peptide receptor of human neutrophils: mapping of binding sites using receptor-mimetic peptides, Biochemistry, 34, 6720, 10.1021/bi00020a017 · doi:10.1021/bi00020a017
  33. Bommakanti, 1993, A carboxyl-terminal tail peptide of neutrophil chemotactic receptor disrupts its physical complex with G protein, J Leukoc Biol, 54, 572, 10.1002/jlb.54.6.572 · doi:10.1002/jlb.54.6.572
  34. Bonnans, 2007, Synthesis and anti-inflammatory effect of lipoxins in human airway epithelial cells, Biomed Pharmacother, 61, 261, 10.1016/j.biopha.2007.02.016 · DOI
  35. Borregaard, 1993, Human neutrophil granules and secretory vesicles, Eur J Haematol, 51, 187, 10.1111/j.1600-0609.1993.tb00629.x · DOI · Paper page
  36. Boulay, 1990, The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors, Biochemistry, 29, 11123, 10.1021/bi00502a016 · DOI · Paper page
  37. Boulay, 1990, Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA, Biochem Biophys Res Commun, 168, 1103, 10.1016/0006-291X(90)91143-G · DOI · Paper page
  38. Boulven, 2006, Class IA phosphatidylinositide 3-kinases, rather than p110 gamma, regulate formyl-methionyl-leucyl-phenylalanine-stimulated chemotaxis and superoxide production in differentiated neutrophil-like PLB-985 cells, J Immunol, 176, 7621, 10.4049/jimmunol.176.12.7621 · DOI
  39. Boxer, 1979, Effects of a chemotactic factor, N-formylmethionyl peptide, on adherence, superoxide anion generation, phagocytosis, and microtubule assembly of human polymorphonuclear leukocytes, J Lab Clin Med, 93, 506
  40. Brazil, 1998, Priming induces functional coupling of N-formyl-methionyl-leucyl-phenylalanine receptors in equine neutrophils, J Leukoc Biol, 63, 380, 10.1002/jlb.63.3.380 · doi:10.1002/jlb.63.3.380
  41. Brink, 2003, International Union of Pharmacology. XXXVII. Nomenclature for leukotriene and lipoxin receptors, Pharmacol Rev, 55, 195, 10.1124/pr.55.1.8 · DOI · Paper page
  42. Brown, 2004, Distinct ligand-dependent roles for p38 MAPK in priming and activation of the neutrophil NADPH oxidase, J Biol Chem, 279, 27059, 10.1074/jbc.M314258200 · DOI
  43. Burg, 1995, G alpha-16 complements the signal transduction cascade of chemotactic receptors for complement factor C5a (C5a-R) and N-formylated peptides (fMLF-R) in Xenopus laevis oocytes: G alpha-16 couples to chemotactic receptors in Xenopus oocytes, FEBS Lett, 377, 426, 10.1016/0014-5793(95)01379-2 · doi:10.1016/0014-5793(95)01379-2
  44. Bürli, 2006, Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents, Bioorg Med Chem Lett, 16, 3713, 10.1016/j.bmcl.2006.04.068 · DOI
  45. Bylund, 2002, Lipopolysaccharide-induced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp(2–20), which activates formyl peptide receptor-like 1, Infect Immun, 70, 2908, 10.1128/IAI.70.6.2908-2914.2002 · DOI
  46. Cai, 2007, Serum amyloid A induces monocyte tissue factor, J Immunol, 178, 1852, 10.4049/jimmunol.178.3.1852 · DOI
  47. Cai, 2005, Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake, J Biol Chem, 280, 2954, 10.1074/jbc.M411555200 · DOI · Paper page
  48. Campbell, 1997, Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration, Eur J Immunol, 27, 2571, 10.1002/eji.1830271016 · DOI
  49. Camps, 1992, Isozyme-selective stimulation of phospholipase C-beta 2 by G protein beta gamma-subunits, Nature, 360, 684, 10.1038/360684a0 · DOI · Paper page
  50. Camps, 1992, Stimulation of phospholipase C by guanine-nucleotide-binding protein beta gamma subunits, Eur J Biochem, 206, 821, 10.1111/j.1432-1033.1992.tb16990.x · DOI · Paper page
  51. Carp, 1982, Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils, J Exp Med, 155, 264, 10.1084/jem.155.1.264 · DOI · Paper page
  52. Cassatella, 1992, IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway, J Immunol, 148, 3216, 10.4049/jimmunol.148.10.3216 · doi:10.4049/jimmunol.148.10.3216
  53. Chen, 1995, Tethered ligand library for discovery of peptide agonists, J Biol Chem, 270, 23398, 10.1074/jbc.270.40.23398 · doi:10.1074/jbc.270.40.23398
  54. Chen, 2003, Akt phosphorylates p47phox and mediates respiratory burst activity in human neutrophils, J Immunol, 170, 5302, 10.4049/jimmunol.170.10.5302 · DOI · Paper page
  55. Chen, 2004, Temporin A and related frog antimicrobial peptides use formyl peptide receptor-like 1 as a receptor to chemoattract phagocytes, J Immunol, 173, 2652, 10.4049/jimmunol.173.4.2652 · DOI
  56. Chen, 2002, Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractants, Biochem Pharmacol, 63, 533, 10.1016/S0006-2952(01)00917-0 · DOI
  57. Chen, 2000, Characterization of chenodeoxycholic acid as an endogenous antagonist of the G-coupled formyl peptide receptors, Inflamm Res, 49, 744, 10.1007/s000110050656 · DOI
  58. Cheng, 2007, A critical role of protein kinase C delta activation loop phosphorylation in formyl-methionyl-leucyl-phenylalanine-induced phosphorylation of p47(phox) and rapid activation of nicotinamide adenine dinucleotide phosphate oxidase, J Immunol, 179, 7720, 10.4049/jimmunol.179.11.7720 · DOI
  59. Chiang, 2000, Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation, J Exp Med, 191, 1197, 10.1084/jem.191.7.1197 · DOI · Paper page
  60. Chiang, 2006, The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo, Pharmacol Rev, 58, 463, 10.1124/pr.58.3.4 · DOI · Paper page
  61. Christenson, 2008, Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1, J Leukoc Biol, 83, 139, 10.1189/jlb.0507276 · DOI
  62. Christophe, 2001, The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2, J Biol Chem, 276, 21585, 10.1074/jbc.M007769200 · DOI · Paper page
  63. Christophe, 2002, Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4, Scand J Immunol, 56, 470, 10.1046/j.1365-3083.2002.01149.x · DOI
  64. Clark, 1977, Defective neutrophil chemotaxis in juvenile periodontitis, Infect Immun, 18, 694, 10.1128/iai.18.3.694-700.1977 · DOI
  65. Colgan, 1993, Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers, J Clin Invest, 92, 75, 10.1172/JCI116601 · DOI
  66. Colotta, 1992, Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products, Blood, 80, 2012, 10.1182/blood.V80.8.2012.2012 · DOI · Paper page
  67. Condliffe, 2005, Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils, Blood, 106, 1432, 10.1182/blood-2005-03-0944 · DOI · Paper page
  68. Cui, 2002, Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer’s disease, J Leukoc Biol, 72, 628, 10.1189/jlb.72.4.628 · DOI
  69. Czapiga, 2005, Human platelets exhibit chemotaxis using functional N-formyl peptide receptors, Exp Hematol, 33, 73, 10.1016/j.exphem.2004.09.010 · DOI
  70. Damian, 2008, G protein activation by the leukotriene B4 receptor dimer. Evidence for an absence of trans-activation, J Biol Chem, 283, 21084, 10.1074/jbc.M710419200 · DOI
  71. D’Andrea, 1989, Expression cloning of the murine erythropoietin receptor, Cell, 57, 277, 10.1016/0092-8674(89)90965-3 · DOI · Paper page
  72. Dang, 2001, Protein kinase C zeta phosphorylates a subset of selective sites of the NADPH oxidase component p47phox and participates in formyl peptide-mediated neutrophil respiratory burst, J Immunol, 166, 1206, 10.4049/jimmunol.166.2.1206 · DOI · Paper page
  73. De Lean, 1980, A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor, J Biol Chem, 255, 7108, 10.1016/S0021-9258(20)79672-9 · DOI · Paper page
  74. de Paulis, 2004, Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2, J Immunol, 173, 5739, 10.4049/jimmunol.173.9.5739 · DOI
  75. de Paulis, 2004, Basophils infiltrate human gastric mucosa at sites of Helicobacter pylori infection, and exhibit chemotaxis in response to H. pylori-derived peptide Hp(2–20), J Immunol, 172, 7734, 10.4049/jimmunol.172.12.7734 · DOI
  76. DeLeo, 1996, Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins, J Leukoc Biol, 60, 677, 10.1002/jlb.60.6.677 · DOI · Paper page
  77. DeLeo, 1998, Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly, J Clin Invest, 101, 455, 10.1172/JCI949 · DOI · Paper page
  78. Deng, 1999, A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R, Blood, 94, 1165, 10.1182/blood.V94.4.1165 · DOI
  79. Derian, 1996, Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues, Biochemistry, 35, 1265, 10.1021/bi952087k · DOI
  80. Devchand, 2003, Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense, Faseb J, 17, 652, 10.1096/fj.02-0770com · DOI · Paper page
  81. Dewas, 2003, TNF-alpha induces phosphorylation of p47(phox) in human neutrophils: partial phosphorylation of p47phox is a common event of priming of human neutrophils by TNF-alpha and granulocyte-macrophage colony-stimulating factor, J Immunol, 171, 4392, 10.4049/jimmunol.171.8.4392 · DOI · Paper page
  82. Dewas, 2000, The mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils, J Immunol, 165, 5238, 10.4049/jimmunol.165.9.5238 · DOI · Paper page
  83. Didsbury, 1991, Receptor class desensitization of leukocyte chemoattractant receptors, Proc Natl Acad Sci U S A, 88, 11564, 10.1073/pnas.88.24.11564 · doi:10.1073/pnas.88.24.11564
  84. Didsbury, 1992, Functional high efficiency expression of cloned leukocyte chemoattractant receptor cDNAs, FEBS Lett, 297, 275, 10.1016/0014-5793(92)80555-U · doi:10.1016/0014-5793(92)80555-u
  85. Dixon, 1986, Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin, Nature, 321, 75, 10.1038/321075a0 · DOI · Paper page
  86. Dohlman, 1991, Model systems for the study of seven-transmembrane-segment receptors, Annu Rev Biochem, 60, 653, 10.1146/annurev.bi.60.070191.003253 · DOI · Paper page
  87. Dolmatch, 1983, Formyl peptide chemotactic receptor. Evidence for an active proteolytic fragment, J Biol Chem, 258, 7570, 10.1016/S0021-9258(18)32216-6 · doi:10.1016/s0021-9258(18)32216-6
  88. Donabedian, 1981, Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe, J Immunol, 127, 839, 10.4049/jimmunol.127.3.839 · doi:10.4049/jimmunol.127.3.839
  89. Dong, 2005, P-Rex1 is a primary Rac2 guanine nucleotide exchange factor in mouse neutrophils, Curr Biol, 15, 1874, 10.1016/j.cub.2005.09.014 · DOI
  90. Dormann, 2002, Visualizing PI3 kinase-mediated cell-cell signaling during Dictyostelium development, Curr Biol, 12, 1178, 10.1016/S0960-9822(02)00950-8 · DOI
  91. Dutil, 1998, Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1), Curr Biol, 8, 1366, 10.1016/S0960-9822(98)00017-7 · DOI · Paper page
  92. Edwards, 2005, Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists, Mol Pharmacol, 68, 1301, 10.1124/mol.105.014068 · DOI
  93. El Benna, 1996, Activation of p38 in stimulated human neutrophils: phosphorylation of the oxidase component p47phox by p38 and ERK but not by JNK, Arch Biochem Biophys, 334, 395, 10.1006/abbi.1996.0470 · DOI
  94. El Kebir, 2007, Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation, J Immunol, 179, 616, 10.4049/jimmunol.179.1.616 · DOI
  95. Elagoz, 2004, A truncated form of CKbeta8–1 is a potent agonist for human formyl peptide-receptor-like 1 receptor, Br J Pharmacol, 141, 37, 10.1038/sj.bjp.0705592 · DOI
  96. Ernst, 2004, An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family, J Immunol, 172, 7669, 10.4049/jimmunol.172.12.7669 · DOI · Paper page
  97. Ernst, 2004, Agonist-induced trafficking of the low-affinity formyl peptide receptor FPRL1, Cell Mol Life Sci, 61, 1684, 10.1007/s00018-004-4116-x · DOI
  98. Finney, 1983, Ligand/receptor internalization: a kinetic, flow cytometric analysis of the internalization of N-formyl peptides by human neutrophils, Cytometry, 4, 54, 10.1002/cyto.990040108 · doi:10.1002/cyto.990040108
  99. Fiore, 1994, Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor, J Exp Med, 180, 253, 10.1084/jem.180.1.253 · DOI · Paper page
  100. Fiore, 1993, Induction of functional lipoxin A4 receptors in HL-60 cells, Blood, 81, 3395, 10.1182/blood.V81.12.3395.3395 · doi:10.1182/blood.v81.12.3395.3395
  101. Fiore, 1992, Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils, J Biol Chem, 267, 16168, 10.1016/S0021-9258(18)41982-5 · DOI
  102. Fletcher, 1983, Human neutrophils contain an intracellular pool of putative receptors for the chemoattractant N-formyl-methionyl-leucyl-phenylalanine, Blood, 62, 792, 10.1182/blood.V62.4.792.792 · DOI
  103. Foxman, 1997, Multistep navigation and the combinatorial control of leukocyte chemotaxis, J Cell Biol, 139, 1349, 10.1083/jcb.139.5.1349 · DOI · Paper page
  104. Foxman, 1999, Integrating conflicting chemotactic signals. The role of memory in leukocyte navigation, J Cell Biol, 147, 577, 10.1083/jcb.147.3.577 · DOI · Paper page
  105. Freer, 1982, Formyl peptide chemoattractants: a model of the receptor on rabbit neutrophils, Biochemistry, 21, 257, 10.1021/bi00531a009 · doi:10.1021/bi00531a009
  106. Freer, 1980, Further studies on the structural requirements for synthetic peptide chemoattractants, Biochemistry, 19, 2404, 10.1021/bi00552a019 · DOI · Paper page
  107. Fu, 2004, The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide, BMC Cell Biol, 5, 50, 10.1186/1471-2121-5-50 · DOI
  108. Fu, 2004, The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8, Immunology, 112, 201, 10.1111/j.1365-2567.2004.01884.x · DOI
  109. Fu, 2003, Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy, Antimicrob Agents Chemother, 47, 2545, 10.1128/AAC.47.8.2545-2550.2003 · doi:10.1128/aac.47.8.2545-2550.2003
  110. Funamoto, 2002, Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis, Cell, 109, 611, 10.1016/S0092-8674(02)00755-9 · DOI · Paper page
  111. Furlan, 2004, The soluble D2D3(88–274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion, J Cell Sci, 117, 2909, 10.1242/jcs.01149 · doi:10.1242/jcs.01149
  112. Gao, 1994, A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor, J Exp Med, 180, 2191, 10.1084/jem.180.6.2191 · DOI
  113. Gao, 1998, Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse, Genomics, 51, 270, 10.1006/geno.1998.5376 · DOI
  114. Gao, 2007, F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor, J Immunol, 178, 1450, 10.4049/jimmunol.178.3.1450 · doi:10.4049/jimmunol.178.3.1450
  115. Gao, 1999, Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor, J Exp Med, 189, 657, 10.1084/jem.189.4.657 · DOI · Paper page
  116. Gao, 1993, Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains, J Biol Chem, 268, 25395, 10.1016/S0021-9258(19)74405-6 · DOI
  117. Gargiulo, 2005, Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide, J Biol Chem, 280, 25225, 10.1074/jbc.M412605200 · doi:10.1074/jbc.m412605200
  118. Gavins, 2003, Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms, Blood, 101, 4140, 10.1182/blood-2002-11-3411 · DOI · Paper page
  119. Gewirtz, 2002, Mechanisms of active intestinal inflammation and potential down-regulation via lipoxins, Adv Exp Med Biol, 507, 229, 10.1007/978-1-4615-0193-0_35 · DOI
  120. Gierschik, 1989, Two distinct Gi-proteins mediate formyl peptide receptor signal transduction in human leukemia (HL-60) cells, J Biol Chem, 264, 21470, 10.1016/S0021-9258(20)88206-4 · doi:10.1016/s0021-9258(20)88206-4
  121. Gilbert, 2001, Internalization of the human N-formyl peptide and C5a chemoattractant receptors occurs via clathrin-independent mechanisms, Biochemistry, 40, 3467, 10.1021/bi001320y · DOI
  122. Godson, 2000, Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages, J Immunol, 164, 1663, 10.4049/jimmunol.164.4.1663 · DOI · Paper page
  123. Goh, 2001, Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophilenterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo, J Immunol, 167, 2772, 10.4049/jimmunol.167.5.2772 · DOI
  124. Goodman, 1996, Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor, Nature, 383, 447, 10.1038/383447a0 · DOI · Paper page
  125. Gripentrog, 2000, Biochem J, 352, 399, 10.1042/bj3520399 · doi:10.1042/bj3520399
  126. Gripentrog, 2008, Formyl peptide receptor-mediated ERK1/2 activation occurs through G(i) and is not dependent on beta-arrestin1/2, Cell Signal, 20, 424, 10.1016/j.cellsig.2007.11.002 · DOI
  127. Gripentrog, 2008, Variable responses of formyl peptide receptor haplotypes toward bacterial peptides, Immunogenetics, 60, 83, 10.1007/s00251-008-0277-3 · doi:10.1007/s00251-008-0277-3
  128. Grumbach, 2009, LXA4 stimulates ZO-1 expression and transepithelial electrical resistance in human airway epithelial (16HBE14o-) cells, Am J Physiol Lung Cell Mol Physiol, 296, L101, 10.1152/ajplung.00018.2008 · doi:10.1152/ajplung.00018.2008
  129. Guichard, 2005, Interleukin-8-induced priming of neutrophil oxidative burst requires sequential recruitment of NADPH oxidase components into lipid rafts, J Biol Chem, 280, 37021, 10.1074/jbc.M506594200 · DOI
  130. Gulden, 1996, A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2–M3 MHC class Ib molecule, Immunity, 5, 73, 10.1016/S1074-7613(00)80311-8 · DOI
  131. Gunji, 2007, Functional polymorphisms of the FPR1 gene and aggressive periodontitis in Japanese, Biochem Biophys Res Commun, 364, 7, 10.1016/j.bbrc.2007.09.105 · doi:10.1016/j.bbrc.2007.09.105
  132. Gwinn, 1999, Single nucleotide polymorphisms of the N-formyl peptide receptor in localized juvenile periodontitis, J Periodontol, 70, 1194, 10.1902/jop.1999.70.10.1194 · DOI
  133. Haas, 2004, N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor, J Immunol, 173, 5704, 10.4049/jimmunol.173.9.5704 · DOI
  134. Hachicha, 1999, Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis, J Exp Med, 189, 1923, 10.1084/jem.189.12.1923 · DOI · Paper page
  135. Han, 2001, Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane translocation, Structure, 9, 869, 10.1016/S0969-2126(01)00644-X · DOI · Paper page
  136. Harada, 2004, N-Formylated humanin activates both formyl peptide receptor-like 1 and 2, Biochem Biophys Res Commun, 324, 255, 10.1016/j.bbrc.2004.09.046 · DOI
  137. HARRIS, 1954, Role of chemotaxis in inflammation, Physiol Rev, 34, 529, 10.1152/physrev.1954.34.3.529 · DOI
  138. Hartt, 1999, N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR, J Exp Med, 190, 741, 10.1084/jem.190.5.741 · DOI
  139. Hartt, 2000, The HIV-1 cell entry inhibitor T-20 potently chemoattracts neutrophils by specifically activating the N-formylpeptide receptor, Biochem Biophys Res Commun, 272, 699, 10.1006/bbrc.2000.2846 · DOI
  140. Hashimoto, 2001, Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer’s disease-relevant insults, J Neurosci, 21, 9235, 10.1523/JNEUROSCI.21-23-09235.2001 · DOI · Paper page
  141. Hayhoe, 2006, Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement, Blood, 107, 2123, 10.1182/blood-2005-08-3099 · DOI · Paper page
  142. He, 2001, Differential roles of the NPXXY motif in formyl peptide receptor signaling, J Immunol, 166, 4099, 10.4049/jimmunol.166.6.4099 · doi:10.4049/jimmunol.166.6.4099
  143. He, 2004, Reconstitution of chemotactic peptide-induced nicotinamide adenine dinucleotide phosphate (reduced) oxidase activation in transgenic COS-phox cells, J Immunol, 173, 7462, 10.4049/jimmunol.173.12.7462 · DOI
  144. He, 2003, Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R, Blood, 101, 1572, 10.1182/blood-2002-05-1431 · DOI · Paper page
  145. Hecht, 2009, A novel peptide agonist of formyl-peptide receptor-like 1 (ALX) displays anti-inflammatory and cardioprotective effects, J Pharmacol Exp Ther, 328, 426, 10.1124/jpet.108.145821 · DOI
  146. Heit, 2008, PTEN functions to ‘prioritize’ chemotactic cues and prevent ‘distraction’ in migrating neutrophils, Nat Immunol, 9, 743, 10.1038/ni.1623 · DOI · Paper page
  147. Heit, 2002, An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients, J Cell Biol, 159, 91, 10.1083/jcb.200202114 · DOI · Paper page
  148. Hepler, 1993, Purification from Sf9 cells and characterization of recombinant Gqα and G11α. Activation of purified phospholipase C isozymes by Gα subunits, J Biol Chem, 268, 14367, 10.1016/S0021-9258(19)85249-3 · DOI · Paper page
  149. Higgins, 1996, N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor, J Med Chem, 39, 1013, 10.1021/jm950908d · DOI
  150. Hirsch, 2000, Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation, Science, 287, 1049, 10.1126/science.287.5455.1049 · DOI · Paper page
  151. Hsu, 1997, Phosphorylation of the N-formyl peptide receptor is required for receptor internalization but not chemotaxis, J Biol Chem, 272, 29426, 10.1074/jbc.272.47.29426 · DOI
  152. Hu, 2001, Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1, J Leukoc Biol, 70, 155, 10.1189/jlb.70.1.155 · DOI
  153. Huet, 2007, The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling, Cell Signal, 19, 1939, 10.1016/j.cellsig.2007.05.006 · DOI
  154. Hughes, 1992, Recruitment of CD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion, J Clin Invest, 90, 1687, 10.1172/JCI116041 · doi:10.1172/jci116041
  155. Jesaitis, 1984, Rapid modulation of N-formyl chemotactic peptide receptors on the surface of human granulocytes: formation of high-affinity ligand-receptor complexes in transient association with cytoskeleton, J Cell Biol, 98, 1378, 10.1083/jcb.98.4.1378 · DOI
  156. Jesaitis, 1985, Membrane-cytoskeleton interactions and the regulation of chemotactic peptide-induced activation of human granulocytes: the effects of dihydrocytochalasin B, J Cell Biochem, 27, 241, 10.1002/jcb.240270306 · DOI
  157. Jiang, 1997, Roles of phospholipase C beta2 in chemoattractant-elicited responses, Proc Natl Acad Sci U S A, 94, 7971, 10.1073/pnas.94.15.7971 · DOI
  158. Jones, 2003, Mutations of F110 and C126 of the formyl peptide receptor interfere with G-protein coupling and chemotaxis, J Periodontol, 74, 475, 10.1902/jop.2003.74.4.475 · DOI
  159. József, 2002, Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes, Proc Natl Acad Sci U S A, 99, 13266, 10.1073/pnas.202296999 · DOI · Paper page
  160. Kamal, 2006, Antiflammin-2 activates the human formyl-peptide receptor like 1, ScientificWorldJournal, 6, 1375, 10.1100/tsw.2006.247 · doi:10.1100/tsw.2006.247
  161. Kanai, 2001, The PX domains of p47phox and p40phox bind to lipid products of PI(3)K, Nat Cell Biol, 3, 675, 10.1038/35083070 · DOI · Paper page
  162. Kang, 2005, The synthetic peptide Trp-Lys-Tyr-Met-Val-d-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2, J Immunol, 175, 685, 10.4049/jimmunol.175.2.685 · DOI
  163. Karlsson, 2006, Biochem Pharmacol, 71, 1488, 10.1016/j.bcp.2006.02.010 · DOI
  164. Karlsson, 2005, Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors, J Leukoc Biol, 78, 762, 10.1189/jlb.0305153 · DOI
  165. Karnad, 1989, Priming of human neutrophils with N-formyl-methionyl-leucyl-phenylalanine by a calcium-independent, pertussis toxin-insensitive pathway, Blood, 74, 2519, 10.1182/blood.V74.7.2519.2519 · doi:10.1182/blood.v74.7.2519.2519
  166. Kettritz, 1997, Neutrophil superoxide release is required for spontaneous and FMLP-mediated but not for TNF alpha-mediated apoptosis, J Am Soc Nephrol, 8, 1091, 10.1681/ASN.V871091 · doi:10.1681/asn.v871091
  167. Key, 2003, N-formyl peptide receptor phosphorylation domains differentially regulate arrestin and agonist affinity, J Biol Chem, 278, 4041, 10.1074/jbc.M204687200 · DOI
  168. Key, 2005, Inhibition of chemoattractant N-formyl peptide receptor trafficking by active arrestins, Traffic, 6, 87, 10.1111/j.1600-0854.2004.00248.x · DOI
  169. Khan, 2005, Lipopolysaccharide: a p38 MAPK-dependent disrupter of neutrophil chemotaxis, Microcirculation, 12, 421, 10.1080/10739680590960368 · DOI
  170. Kim, 2003, The hemopoietic Rho/Rac guanine nucleotide exchange factor Vav1 regulates N-formyl-methionyl-leucyl-phenylalanine-activated neutrophil functions, J Immunol, 171, 4425, 10.4049/jimmunol.171.8.4425 · DOI
  171. Kim, 1993, N-linked glycosylation of the receptor for murine ecotropic retroviruses is altered in virus-infected cells, J Biol Chem, 268, 16316, 10.1016/S0021-9258(19)85423-6 · doi:10.1016/s0021-9258(19)85423-6
  172. Kim, 2006, Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl peptide receptor-like 1, J Immunol, 176, 2969, 10.4049/jimmunol.176.5.2969 · DOI
  173. Klein, 1998, Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast, Nat Biotechnol, 16, 1334, 10.1038/4310 · DOI
  174. Knaus, 1991, Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2, Science, 254, 1512, 10.1126/science.1660188 · DOI · Paper page
  175. Kobilka, 1987, Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor, Science, 238, 650, 10.1126/science.2823383 · DOI · Paper page
  176. Koczulla, 2003, An angiogenic role for the human peptide antibiotic LL-37/hCAP-18, J Clin Invest, 111, 1665, 10.1172/JCI17545 · DOI · Paper page
  177. Kodama, 1999, Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production, Biochem J, 337, 201, 10.1042/bj3370201 · DOI
  178. Kohout, 2001, beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking, Proc Natl Acad Sci U S A, 98, 1601
  179. König, 1989, Three cytoplasmic loops of rhodopsin interact with transducin, Proc Natl Acad Sci U S A, 86, 6878, 10.1073/pnas.86.18.6878 · DOI · Paper page
  180. Koo, 1982, The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity states, Biochem Biophys Res Commun, 106, 442, 10.1016/0006-291X(82)91130-5 · doi:10.1016/0006-291x(82)91130-5
  181. Koo, 1983, Guanine nucleotides modulate the binding affinity of the oligopeptide chemoattractant receptor on human polymorphonuclear leukocytes, J Clin Invest, 72, 748, 10.1172/JCI111045 · DOI
  182. Korchak, 1984, Stimulus response coupling in the human neutrophil. Differential requirements for receptor occupancy in neutrophil responses to a chemoattractant, J Biol Chem, 259, 7439, 10.1016/S0021-9258(17)42810-9 · DOI
  183. Kozasa, 1993, Purification and characterization of recombinant G16 alpha from Sf9 cells: activation of purified phospholipase C isozymes by G-protein alpha subunits, Proc Natl Acad Sci U S A, 90, 9176, 10.1073/pnas.90.19.9176 · DOI
  184. Kubo, 1986, Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor, Nature, 323, 411, 10.1038/323411a0 · DOI · Paper page
  185. Kucharzik, 2003, Lateral membrane LXA4 receptors mediate LXA4’s anti-inflammatory actions on intestinal epithelium, Am J Physiol Cell Physiol, 284, C888, 10.1152/ajpcell.00507.2001 · DOI
  186. Kurosaka, 2005, Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant, J Immunol, 174, 6257, 10.4049/jimmunol.174.10.6257 · DOI
  187. Lacy, 1995, Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia, J Neuroimmunol, 61, 71, 10.1016/0165-5728(95)00075-D · DOI · Paper page
  188. Lad, 1985, Association of the N-formyl-Met-Leu-Phe receptor in human neutrophils with a GTP-binding protein sensitive to pertussis toxin, Proc Natl Acad Sci U S A, 82, 869, 10.1073/pnas.82.3.869 · DOI · Paper page
  189. Lad, 1977, Evidence for distinct guanine nucleotide sites in the regulation of the glucagon receptor and of adenylate cyclase activity, J Biol Chem, 252, 5942, 10.1016/S0021-9258(17)40009-3 · doi:10.1016/s0021-9258(17)40009-3
  190. Laporte, 2002, β-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a β-arrestin binging site in β2-adaptin, J Biol Chem, 277, 9247, 10.1074/jbc.M108490200 · DOI
  191. Lavigne, 2002, The N-formylpeptide receptor (FPR) and a second G(i) -coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils, Cell Immunol, 218, 7, 10.1016/S0008-8749(02)00564-6 · DOI
  192. Le, 1999, Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation, J Immunol, 163, 6777, 10.4049/jimmunol.163.12.6777 · DOI · Paper page
  193. Le, 2001, Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1, J Neurosci, 21, RC123, 10.1523/JNEUROSCI.21-02-j0003.2001 · DOI · Paper page
  194. Le, 2000, Expression of functional formyl peptide receptors by human astrocytoma cell lines, J Neuroimmunol, 111, 102, 10.1016/S0165-5728(00)00373-8 · DOI
  195. Le, 2000, N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes, Clin Immunol, 96, 236, 10.1006/clim.2000.4896 · DOI
  196. Le, 2002, Formyl-peptide receptors revisited, Trends Immunol, 23, 541, 10.1016/S1471-4906(02)02316-5 · DOI · Paper page
  197. Le, 2001, Pleiotropic roles of formyl peptide receptors, Cytokine Growth Factor Rev, 12, 91, 10.1016/S1359-6101(01)00003-X · DOI · Paper page
  198. Le, 2001, The neurotoxic prion peptide fragment PrP(106–126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1, J Immunol, 166, 1448, 10.4049/jimmunol.166.3.1448 · DOI
  199. Le, 2005, Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis, FEBS J, 272, 769, 10.1111/j.1742-4658.2004.04514.x · DOI
  200. Lee, 2005, Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells, Biochem Biophys Res Commun, 330, 989, 10.1016/j.bbrc.2005.03.069 · DOI

200 of 392 shown

Cited by

See all 764

Metadata

Authors
Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C. N., & Murphy, P. M.
Venue
Pharmacological Reviews
Publisher
Elsevier BV
Published
2009-06
Volume
61
Issue
2
Pages
119-161
ISSN
0031-6997 (ISSN-L)
DOI
10.1124/pr.109.001578
OpenAlex
W2131896212
Cited by
764
References
6
FWCI
21.03
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family. https://app.cochat.ai/papers/10.1124/pr.109.001578
The paper
Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C. N., & Murphy, P. M. (2009). International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family. Pharmacological Reviews. https://doi.org/10.1124/pr.109.001578

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.